MMRF PRESS RELEASES
Precious Cat Partners with the Multiple Myeloma Research Foundation (MMRF) to Advance Cancer Research
Norwalk, CT — December 7, 2011
The Multiple Myeloma Research Foundation (MMRF) today announced that it has partnered with Precious Cat Litters to raise an ambitious $5 million needed by year-end to together advance the research and development of new treatments for multiple myeloma, an incurable blood cancer. Through this partnership, Precious Cat has made a very generous commitment to the MMRF in the hope that it will be matched with gifts from other donors during the year-end Fast Forward To A Multiple Myeloma Cure (FFWD2MMCURE) campaign.
“We are proud to partner with the MMRF to advance their cutting-edge research portfolio and are excited to offer all cat lovers the opportunity to also support cancer research,” said Kathy Elsey, co-founder of Precious Cat, who was diagnosed with multiple myeloma in 2009. “As a patient myself, I feel blessed to be able to bring Precious Cat Litters together with the MMRF to bring patients the new treatments they so urgently need.”
Kathy Giusti, the Founder and CEO of the MMRF, is also a multiple myeloma patient. Both Elsey and Giusti, who share the same spirited approach to facing the challenges of their disease, stand as shining examples of the important role philanthropic women entrepreneurs play in today’s world.
“Like Kathy Giusti, Kathy Elsey is an inspiration to all those who are fighting multiple myeloma both as a patient and as one of the MMRF’s most generous and committed donors,” said Walter Capone, COO of the MMRF. “We are deeply honored and excited to partner with Precious Cat to identify the most promising new drugs and advance them rapidly through clinical trials so patients can receive new treatments faster than ever before.”
This philanthropic partnership marks the latest in a history of charitable giving to the MMRF by Precious Cat. In 2010, Precious Cat donated 100% of all product sales for the month of November to the MMRF. Earlier this year, Precious Cat designated the MMRF the beneficiary of a Cats Save Lives campaign. To learn more, visit www.themmrf.org/Elsey. To date, Precious Cat has donated an incredible $3.4 million to support multiple myeloma research and accelerate the development of new therapies.
About the Multiple Myeloma Research Foundation (MMRF)
The Multiple Myeloma Research Foundation (MMRF) was established in 1998 as a 501(c)(3) non-profit organization by twin sisters Karen Andrews and Kathy Giusti, soon after Kathy's diagnosis with multiple myeloma. The mission of the MMRF is to relentlessly pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and lead to a cure. As the world's number-one private funder of multiple myeloma research, the MMRF has raised over $170 million since its inception and directs 90% of total budget to research and related programming. As a result, the MMRF has been awarded Charity Navigator’s coveted 4 star rating for 8 consecutive years, the highest designation for outstanding fiscal responsibility and exceptional efficiency. For more information about the MMRF, please visit www.themmrf.org.
About Precious Cat
Dr. Bruce Elsey, DVM, is a feline-only veterinarian. His veterinary clinic cares for more than 8,000 cats. With over 30 years of experience, Dr. Elsey is an expert and visionary in the industry and uses his background to provide innovative solutions for cats and their owners. Dr. Elsey co-founded Precious Cat, Inc. in 1989 with his wife Kathy Elsey to provide a solution through quality cat litters that help cats live happier, healthier lives. The Precious Cat product line includes problem cat and kitten training litters Cat Attract and Kitten Attract, Ultra Litter Attractant, Precious Cat Classic, Precious Cat Ultra, Precious Cat Senior and Long Hair litters, and now Respiratory Relief Litter. For more information about Precious Cat products please call 877-311-2287 or visit www.preciouscat.com.
About Multiple Myeloma
Multiple myeloma is an incurable blood cancer. The five-year relative survival rate for multiple myeloma is approximately 38 percent, one of the lowest of all cancers. In 2011, more than 20,000 adults in the United States will be diagnosed with multiple myeloma and nearly 11,000 people are predicted to die from the disease.